Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TRPM1-AS1 (TRPM1 antisense RNA 1) is a long non-coding RNA transcribed in the antisense direction to the TRPM1 gene. While TRPM1 encodes a cation channel protein involved in visual signaling and is implicated in conditions such as congenital stationary night blindness and melanoma, no detailed information or therapeutic relevance is reported for the antisense RNA TRPM1-AS1 in the search results. All available references describe only TRPM1 (the ion channel), not TRPM1-AS1. For structured and validated target information, TRPM1 is a well-defined protein, while TRPM1-AS1 lacks coverage and may not be an established drug target or characterized molecule according to databases and scientific literature reviewed. If searching for "TRPM1-AS1" in drug or target databases, results may be incomplete or absent, and this molecule should be marked as lacking sufficient information or not currently recognized as a therapeutic target. If more precise data about TRPM1-AS1 is required (e.g., non-coding RNA function in disease, interaction with drugs, etc.), further literature review or experimental database queries will be necessary.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TRPM1 antisense RNA 1 (TRPM1-AS1).